AB0587 Limitations of the 1990 American College of Rheumatology Criteria in the Classification of Cutaneous Vasculitis. Study of 773 Cutaneous Vasculitis

Autor: M. Arias, Vanesa Calvo-Río, L. Άlvarez, M. A. González-Gay, M.E. Peirό, Francisco Ortiz-Sanjuán, Ricardo Blanco, Trinitario Pina, María Carmen González-Vela, M.A. González-Lόpez, Javier Loricera, M. Santos-Gόmez, Javier Rueda-Gotor, Luis Cuadrado Martin
Rok vydání: 2014
Předmět:
Zdroj: Annals of the Rheumatic Diseases. 73:1000.1-1000
ISSN: 1468-2060
0003-4967
DOI: 10.1136/annrheumdis-2014-eular.3111
Popis: Background In 1990 The American College of Rheumatology (ACR) established criteria for the classification of vasculitis. Cutaneous vasculitis (CV) comprises a wide and heterogeneous group of entities. Objectives Our aim was to revise the usefulness of ACR-1990 criteria in classifying patients with CV. Methods Retrospective study of a wide and unselected series of patients with CV from a single university hospital from January 1976 to January 2012. Patients were classified according to the 1990 ACR methodology and criteria. Results 773 Patients (351 women/422 men) with a mean age of 34.1±27.4 years were diagnosed as having CV. Applying the 1990 ACR criteria patients were classified as secondary to connective tissue diseases (n=35), major infections (n=27), malignancies (n=16), mixed essential cryoglobulinemia (n=13), Wegener Granulomatosis (n=3), Churg-Strauss syndrome (n=3) and Polyarteritis nodosa (n=3). The remaining 673 patients were classified as Hipersensitivity vasculitis (n=247; 36.6%) or Henoch Schonlein Purpura (n=414; 61.4%). Disappointingly, 127 (18.8%) met criteria for both entities and 12 out of 673 cases did not meet criteria for HV nor HSP and were not classified. Conclusions The ACR-1990 criteria for vasculitis do not properly classify patients with CV. Acknowledgements This study was supported by a grant from “Fondo de Investigaciones Sanitarias” PI12/00193 (Spain). This work was also partially supported by RETICS Programs, RD08/0075 (RIER) and RD12/0009/0013 from “Instituto de Salud Carlos III” (ISCIII) (Spain). Disclosure of Interest None declared DOI 10.1136/annrheumdis-2014-eular.3111
Databáze: OpenAIRE